Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05867342
Other study ID # 40274
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date May 12, 2017
Est. completion date August 22, 2018

Study information

Verified date June 2023
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In endoscopic sinus surgery a clear surgical field of view is a very important aspect for good surgical outcome. This study is to evaluate the preoperative preparation to acquire best surgical field of view by comparing between the use of topical adrenaline and the use of combination of topical adrenaline with infiltration of 1% lidocaine with adrenaline in patients scheduled for endoscopic sinus surgery for rhinosinusitis.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date August 22, 2018
Est. primary completion date August 22, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Diagnosed with recurrent acute or chronic rhinosinusitis recalcitrant to medical treatment and scheduled for endoscopic sinus surgery Exclusion Criteria: - Patients who have asymetrical disease on the two sides (Lund Mackay score difference more than 2) - Patients who have endoscopic sinus surgery for treatment of tumor or disease other than sinusitis - Patients with underlying uncontrolled hypertension - Patients with bleeding disorder or are unable to discontinue antiplatelet or anticoagulant before the surgery - Patients who are allergic to adrenaline or to xylocaine

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Epinephrin
Topical application of 2 pieces of Epinephrin (1:1,000)-soaked cottonoid in nasal cavity
1% lidocaine with epinephrin 1:100,000
4 ml intranasal infiltration of 1% lidocaine with epinephrine (1:100,000) at 2 sites (2 ml infiltration at each site)
Saline
4 ml intranasal infiltration of saline at 2 sites (2 ml infiltration at each site)

Locations

Country Name City State
United States Stanford Stanford California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

References & Publications (7)

Cohen-Kerem R, Brown S, Villasenor LV, Witterick I. Epinephrine/Lidocaine injection vs. saline during endoscopic sinus surgery. Laryngoscope. 2008 Jul;118(7):1275-81. doi: 10.1097/MLG.0b013e31816dd2d9. — View Citation

Khosla AJ, Pernas FG, Maeso PA. Meta-analysis and literature review of techniques to achieve hemostasis in endoscopic sinus surgery. Int Forum Allergy Rhinol. 2013 Jun;3(6):482-7. doi: 10.1002/alr.21126. Epub 2012 Dec 16. — View Citation

Moshaver A, Lin D, Pinto R, Witterick IJ. The hemostatic and hemodynamic effects of epinephrine during endoscopic sinus surgery: a randomized clinical trial. Arch Otolaryngol Head Neck Surg. 2009 Oct;135(10):1005-9. doi: 10.1001/archoto.2009.144. — View Citation

Saif AM, Farboud A, Delfosse E, Pope L, Adke M. Assessing the safety and efficacy of drugs used in preparing the nose for diagnostic and therapeutic procedures: a systematic review. Clin Otolaryngol. 2016 Oct;41(5):546-63. doi: 10.1111/coa.12563. Epub 2016 Feb 11. — View Citation

Tangbumrungtham N, Hwang PH, Maul X, Borchard NA, Dholakia SS, Patel ZM, Nayak JV, Choby G. The effect of topical epinephrine 1:1000 with and without infiltration of 1% lidocaine with epinephrine 1:100,000 on endoscopic surgical field visualization: a dou — View Citation

Yang JJ, Li WY, Jil Q, Wang ZY, Sun J, Wang QP, Li ZQ, Xu JG. Local anesthesia for functional endoscopic sinus surgery employing small volumes of epinephrine-containing solutions of lidocaine produces profound hypotension. Acta Anaesthesiol Scand. 2005 Nov;49(10):1471-6. doi: 10.1111/j.1399-6576.2005.00869.x. — View Citation

Yang JJ, Zheng J, Liu HJ, Liu YX, Shen JC, Zhou ZQ. Epinephrine infiltration on nasal field causes significant hemodynamic changes: hypotension episode monitored by impedance-cardiography under general anesthesia. J Pharm Pharm Sci. 2006;9(2):190-7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Surgical Field Grading Score The video recording of the endoscopic sinus surgery of the participant was graded by another otolaryngology specialist postoperatively and graded according to Wormald Surgical Field Grading Scale. Scores range from 0 (no bleeding) to 10 (severe bleeding with nasal cavity filling rapidly). postoperatively (approximately 20 minutes to assess)
Secondary Duration of Surgery intraoperatively (up to 3 hours)
Secondary Number of Extra Pledgets Used A pledget is a small wad of absorbent material used to stop bleeding. intraoperatively (up to 3 hours)
Secondary Estimated Blood Loss During Surgery intraoperatively (up to 3 hours)
Secondary Postoperative Bloody Discharge Grading Score Grading of postoperative bloody discharge postoperatively assessed by patient using the 1-week postoperative bleeding questionnaire. Scores range from 0 (no bleeding) to 5 (continuous heavy bleeding necessitating medical care). 1 week after the surgery (up to 2 minutes to complete assessment)
Secondary Number of Days With Postoperative Bloody Nasal Discharge Participants indicated number of days with bloody nasal discharge postoperatively using the 1-week postoperative bleeding questionnaire. 1 week after the surgery (up to 2 minutes to complete assessment)
Secondary Number of Nostrils With Continuous Fresh Bleeding Number of nostrils with excessive fresh bleeding postoperatively using the 1-week postoperative bleeding questionnaire. Continuous fresh bleeding was defined as bleeding for over 15 minutes. 1 week after the surgery (up to 2 minutes to complete assessment)
See also
  Status Clinical Trial Phase
Recruiting NCT05900037 - GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery N/A
Recruiting NCT04609410 - Bleeding in Laparoscopic Liver Surgery N/A
Terminated NCT01458561 - Adjunctive Application of BioFoam Surgical Matrix in Liver Surgery Phase 3
Completed NCT01651806 - Weighted Versus Uniform Dose of Tranexamic Acid in Patients Undergoing Primary, Knee Arthroplasty Phase 2/Phase 3
Completed NCT01656759 - Use of a Novel Fibrin Sealant in Total Knee Arthroplasty Phase 2/Phase 3
Not yet recruiting NCT05841251 - Phenylephrine Versus Tranexamic Acid to Control Bleeding in Patients Undergoing Inferior Turbinoplasty by Coblation N/A
Not yet recruiting NCT06450834 - Ostene in Thoracolumbar Decompression and Fusion Evaluated With VIBE
Not yet recruiting NCT06427707 - The Effect of Adding Either Propofol or Ketamine to Magnesium and Lidocaine Infusions in Nasal Surgeries. Phase 2/Phase 3
Active, not recruiting NCT01539057 - The Efficacy of the Administration of Fibrinogen in Liver Transplantation Phase 3
Completed NCT03820206 - The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women N/A
Completed NCT01891461 - Study to Compare the Addition of Floseal to Our Standard of Care to Control Post Operative Bleeding in TKR Phase 4
Completed NCT03047070 - Lidocaine in ERAS for FESS Phase 2
Completed NCT04188184 - Tranexamic Acid Versus Epinephrine During Exploratory Tympanotomy N/A
Recruiting NCT04697498 - Bilateral Bi-level Erector Spine Plane Block as a Component of General Anesthesia in Surgical Correction of Spinal Deformations N/A
Completed NCT05385952 - GATT-Patch Versus TachoSil in Liver Surgery N/A
Completed NCT02229292 - Prevention of Intraoperative Bleeding and Postoperative Swelling in Orthognathic Surgery Through the Use of Tranexamic Acid Phase 4
Not yet recruiting NCT06264596 - Epinephrine in Irrigation Fluid for Visualization During Ankle Surgery Phase 3
Recruiting NCT03112135 - Effect of Topical and Systemic Tranexemic Acid on Bleeding During Ear Exploration Surgery Phase 2
Recruiting NCT06399445 - Measurement of Blood Loss in Adenotonsillectomy During General Anesthesia According to the Application of Nondepolarizing Muscle Relaxants Phase 4